Growing community of inventors

Boston, MA, United States of America

Nikolaos Patsoukis

Average Co-Inventor Count = 8.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Nikolaos PatsoukisGordon James Freeman (2 patents)Nikolaos PatsoukisArlene Helen Sharpe (2 patents)Nikolaos PatsoukisVassiliki A Boussiotis (2 patents)Nikolaos PatsoukisVikram R Juneja (2 patents)Nikolaos PatsoukisXia Bu (2 patents)Nikolaos PatsoukisJessica Weaver (2 patents)Nikolaos PatsoukisLaura Strauss (2 patents)Nikolaos PatsoukisNikolaos Patsoukis (2 patents)Gordon James FreemanGordon James Freeman (90 patents)Arlene Helen SharpeArlene Helen Sharpe (35 patents)Vassiliki A BoussiotisVassiliki A Boussiotis (9 patents)Vikram R JunejaVikram R Juneja (3 patents)Xia BuXia Bu (2 patents)Jessica WeaverJessica Weaver (2 patents)Laura StraussLaura Strauss (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Harvard College (2 from 2,968 patents)

2. Dana-farber-cancer Institute Inc. (2 from 1,210 patents)

3. Beth Israel Deaconess Medical Center, Inc. (2 from 517 patents)


2 patents:

1. 12258409 - Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies

2. 11492403 - Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…